$5.07
-0.42-7.65%
At close: -
$4.95
-0.12-2.37%
After Hours: Dec 20, 8:27 AM EDT
Evoke Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Evoke Pharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $-0.94 | $-0.38 | -147.4 % |
Jun 2024 | 2024-08-13 | $-0.93 | $-0.72 | -29.2 % |
Mar 2024 | 2024-05-14 | $-2.04 | $-2.52 | 19.1 % |
Dec 2023 | 2024-03-14 | $-7.08 | $-6.00 | -18.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $2.65M | $3.36M | -21.0 % |
Jun 2024 | 2024-08-13 | $2.55M | $2.98M | -14.4 % |
Mar 2024 | 2024-05-14 | $1.74M | $2.14M | -18.9 % |
Dec 2023 | 2024-03-14 | $1.68M | $1.63M | 2.82 % |
Evoke Pharma (EVOK) is scheduled to report earnings on March 13, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
The Actual EPS was $-0.94, which missed the estimate of $-0.38.
The Actual Revenue was $2.7M, which missed the estimate of $3.4M.
Browse earnings estimates, EPS, and revenue on all stocks.